AI steps in to spot eye disease in underserved communities
NCT ID NCT06629649
Summary
This study aims to test an artificial intelligence (AI) eye screening program in community health centers that serve low-income and uninsured patients. It will screen 1,800 adults at risk for glaucoma, diabetic retinopathy, cataracts, or vision problems to see if the program effectively detects these conditions and if patients follow up with an eye doctor. The research will also compare the cost and satisfaction of this AI-assisted screening to traditional doctor-led methods.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Ophthalmology and Visual Sciences, University of Alabama at Birmingham
RECRUITINGBirmingham, Alabama, 35294-0009, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.